Users of Ozempic and other drugs are shunning items like energy drinks and salty snacks, research shows. But there are ...
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effi ...
Investigational once-weekly retatrutide yielded the greatest weight loss of all GLP-1 receptor agonists, up to 22.1% after 48 ...
HealthDay News — For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published ...
Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation. (HealthDay News) — For adults with overweight or obesity without ...
What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...